These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

91 related items for PubMed ID: 874818

  • 21. The pharmacology of verapamil. IV. Kinetic and dynamic effects after single intravenous and oral doses.
    McAllister RG, Kirsten EB.
    Clin Pharmacol Ther; 1982 Apr; 31(4):418-26. PubMed ID: 7060323
    [Abstract] [Full Text] [Related]

  • 22. Verapamil disposition kinetics in chronic atrial fibrillation.
    Kates RE, Keefe DL, Schwartz J, Harapat S, Kirsten EB, Harrison DC.
    Clin Pharmacol Ther; 1981 Jul; 30(1):44-51. PubMed ID: 7237897
    [Abstract] [Full Text] [Related]

  • 23. [The effects of slow-release verapamil in relation to plasma concentration in aged hypertensives. A study with continuous monitoring of arterial pressure and electrocardiogram].
    Canonico V, Bonaduce D, De Caprio L, Nicolino A, Forgione L, Petretta M, Rengo F.
    G Ital Cardiol; 1990 Oct; 20(10):924-32. PubMed ID: 2090531
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 26. Prediction of steady-state verapamil plasma concentrations in children and adults.
    Wagner JG, Rocchini AP, Vasiliades J.
    Clin Pharmacol Ther; 1982 Aug; 32(2):172-81. PubMed ID: 7094504
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. Cimetidine interaction with dipotassium clorazepate disposition in the anesthetized dog.
    Colin P, Sirois G, Lelorier J.
    Arch Int Pharmacodyn Ther; 1984 Mar; 268(1):12-24. PubMed ID: 6145392
    [Abstract] [Full Text] [Related]

  • 30.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 31.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 32. Clinical pharmacokinetics of verapamil in patients with atrial fibrillation.
    Anderson P, BondessoN U, Sylvén C.
    Eur J Clin Pharmacol; 1982 Mar; 23(1):49-57. PubMed ID: 7128672
    [Abstract] [Full Text] [Related]

  • 33. Comparison of intravenous and oral verapamil dosing.
    Reiter MJ, Shand DG, Pritchett EL.
    Clin Pharmacol Ther; 1982 Dec; 32(6):711-20. PubMed ID: 7140136
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Age-related changes in the pharmacodynamics of verapamil.
    Arnold TH, Vallner JJ, Tackett RL.
    Am Heart J; 1985 Nov; 110(5):981-5. PubMed ID: 4061274
    [Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.